Merck diabetes pill combination wins U.S. approval - Yahoo! News
Merck & Co Inc. has won U.S. approval to sell a medicine called Janumet that combines two diabetes medicines into a single pill, the
Food and Drug Administration said on Saturday.
Janumet pairs Merck's drug Januvia with a widely used, older generic medicine called metformin. Both drugs help control blood sugar in patients with Type 2 diabetes, the most common form.
Januvia was approved last October as the first medicine in a new class called dipeptidyl peptidase-4 inhibitors, or DPP-4 inhibitors. Januvia's generic name is sitagliptin.
Powered by ScribeFire.